United States Market Monthly Performance for December 2024

Eli Lilly and consolidates with a 4-month decline (957.77 → 772.00), down 19.4%. However, fundamentals remain robust: 12.7B revenue generating 2.8B profit (21.7% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note. Even with 21.7% margins, mega-caps face valuation resets when growth slows.

Coca-Cola pulls back after a 4-month decline (72.44 → 62.26), down 14.1%. However, fundamentals remain robust: 11.1B revenue generating 3.3B profit (30.0% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note. Even with 30.0% margins, mega-caps face valuation resets when growth slows.

Devon Energy experiences extended pressure with a 8-month decline (50.96 → 32.73), down 35.8%. Revenue of 4.5B provides a foundation, but 509.0M net income (11.4% margin) in Qtr ending Mar 2025 highlights operational challenges that need addressing. At 88.3% operating efficiency, focus shifts to margin preservation during downturn.

Celsius Holdings encounters challenges with a 7-month decline (79.16 → 26.34), down 66.7%. However, fundamentals remain robust: 329.3M revenue generating 44.4M profit (13.5% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note. Despite solid 13.5% margins, large-caps aren't immune to sentiment shifts.

Axcelis encounters challenges with a 6-month decline (142.19 → 69.87), down 50.9%. However, fundamentals remain robust: 192.6M revenue generating 28.6M profit (14.8% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note. Mid-cap volatility despite strong fundamentals creates value opportunities.

Moderna encounters challenges with a 5-month decline (99.58 → 41.58), down 58.2%. Financial struggles compound the decline: despite 107.0M revenue, - 971.0M losses persist (-907.5% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted. Mid-cap flexibility becomes crucial when growth stalls and margins compress.

Goldman Sachs BDC experiences extended pressure with a 8-month decline (15.51 → 12.10), down 22.0%. Weak margins on 35.2M revenue with only 31.6M profit (89.7% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts. Thin margins leave little room for error in unforgiving small-cap markets.

Dorian LPG sees continued selling pressure through a 7-month decline (51.13 → 24.37), down 52.3%. However, fundamentals remain robust: 75.9M revenue generating 8.1M profit (10.7% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note. Small-cap selloffs often ignore fundamentals, creating mispricing opportunities.